98 related articles for article (PubMed ID: 35484177)
1. Identification and validation of prognosis-associated DNA repair gene signatures in colorectal cancer.
Song D; Zhang D; Chen S; Wu J; Hao Q; Zhao L; Ren H; Du N
Sci Rep; 2022 Apr; 12(1):6946. PubMed ID: 35484177
[TBL] [Abstract][Full Text] [Related]
2. Identification and Validation of a Novel DNA Damage and DNA Repair Related Genes Based Signature for Colon Cancer Prognosis.
Wang XQ; Xu SW; Wang W; Piao SZ; Mao XL; Zhou XB; Wang Y; Wu WD; Ye LP; Li SW
Front Genet; 2021; 12():635863. PubMed ID: 33719345
[No Abstract] [Full Text] [Related]
3. Exosome secretion related gene signature predicts chemoresistance in patients with colorectal cancer.
Ming L; Tang J; Qin F; Qin Y; Wang D; Huang L; Cao Y; Huang Z; Yin Y
Pathol Res Pract; 2024 May; 257():155313. PubMed ID: 38642509
[TBL] [Abstract][Full Text] [Related]
4. DNA damage repair molecular subtype derived immune signature applicable for the prognosis and immunotherapy response prediction in colon cancer.
Shang Z; Wang Z; Zhang Y; Liu S
Transl Cancer Res; 2023 Oct; 12(10):2781-2805. PubMed ID: 37969400
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
[TBL] [Abstract][Full Text] [Related]
6. A novel prognostic signatures based on metastasis- and immune-related gene pairs for colorectal cancer.
Pan B; Yue Y; Ding W; Sun L; Xu M; Wang S
Front Immunol; 2023; 14():1161382. PubMed ID: 37180113
[TBL] [Abstract][Full Text] [Related]
7. Chemokine- and chemokine receptor-based signature predicts immunotherapy response in female colorectal adenocarcinoma patients.
Zhu W; Wu C; Hu S; Liu S; Zhao S; Zhang D; Qiu G; Cheng X; Huang J
Sci Rep; 2023 Dec; 13(1):21358. PubMed ID: 38049474
[TBL] [Abstract][Full Text] [Related]
8. Identification of glutamine metabolism-related gene signature to predict colorectal cancer prognosis.
Xie Y; Li J; Tao Q; Wu Y; Liu Z; Zeng C; Chen Y
J Cancer; 2024; 15(10):3199-3214. PubMed ID: 38706895
[No Abstract] [Full Text] [Related]
9. Identification of macrophage-related molecular subgroups and risk signature in colorectal cancer based on a bioinformatics analysis.
Liu Q; Liao L
Autoimmunity; 2024 Dec; 57(1):2321908. PubMed ID: 38466182
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of epigenetic modification-related signals for the diagnosis and prognosis of colorectal cancer.
Li X; Li J; Li J; Liu N; Zhuang L
BMC Genomics; 2024 Jan; 25(1):51. PubMed ID: 38212708
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of a Novel Prognostic Gene Model for Colorectal Cancer.
Meng Y; Zhou R; Lin Z; Peng Q; Ding J; Huang M; Li Y; Guo X; Zhuang K
Comput Math Methods Med; 2022; 2022():9774219. PubMed ID: 35924107
[TBL] [Abstract][Full Text] [Related]
12. Identification of a 5-Nutrient Stress-Sensitive Gene Signature to Predict Survival for Colorectal Cancer.
Xiong J; Xiong S; Feng X; Zhang H; Su Q
Biomed Res Int; 2022; 2022():2587120. PubMed ID: 35496037
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of a NAD+ metabolism-derived gene signature to predict the prognosis and immune landscape in endometrial cancer.
Hu D; Du J; Cheng Y; Xing Y; He R; Liang X; Li H; Yang Y
Biomol Biomed; 2024 Mar; 24(2):346-359. PubMed ID: 37688492
[TBL] [Abstract][Full Text] [Related]
14. Prognostic signature of colorectal cancer based on uric acid-related genes.
Zhuang C; Liu Y; Gu R; Du S; Long Y
Heliyon; 2023 Dec; 9(12):e22587. PubMed ID: 38213580
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of a prognostic signature based on six immune-related genes for colorectal cancer.
Zheng L; Xu Z; Zhang W; Lin H; Zhang Y; Zhou S; Liu Z; Gu X
Discov Oncol; 2024 May; 15(1):192. PubMed ID: 38806963
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of a novel six-gene signature based on mucinous adenocarcinoma-related gene molecular typing in colorectal cancer.
Man Y; Xin D; Ji Y; Liu Y; Kou L; Jiang L
Discov Oncol; 2024 Mar; 15(1):63. PubMed ID: 38443703
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel six DNA damage response-related prognostic signature in osteosarcoma.
Li T; Tang Z; Li S; Lu M
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):110-115. PubMed ID: 38650147
[TBL] [Abstract][Full Text] [Related]
18. Identification of the shared gene signature and biological mechanism between type 2 diabetes and colorectal cancer.
Liu X; Li D; Gao W; Zhao W; Jin L; Chen P; Liu H; Zhao Y; Dong G
Front Genet; 2023; 14():1202849. PubMed ID: 37876593
[No Abstract] [Full Text] [Related]
19. A centrosome-related gene signature for predicting the overall survival of uveal melanoma.
Yu X; Guo X; Li W; Li J
Transl Cancer Res; 2024 Feb; 13(2):771-781. PubMed ID: 38482432
[TBL] [Abstract][Full Text] [Related]
20. The Predictive Value of Neutrophil Extracellular Trap-Related Risk Score in Prognosis and Immune Microenvironment of Colorectal Cancer Patients.
Dong J; Zhao J; Wu Z; Liu J; Wang B; Qi X
Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38580851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
